Breast Cancer Clinical Trial

Assessing the Sensitivity of “SureTouch™” in Women Undergoing Diagnostic and Screening Mammography

Summary

Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.

View Full Description

Full Description

This is a single-center, prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.

Results of the mammography will be compared to the SureTouch examination results.

Subjects will have between 1 and 3 research visits and 3 follow-up surveys, up to two years from the initial visit. The number of visits will be based upon comparison of the SureTouch examination to conventional breast screening techniques (mammogram and ultrasound).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Arm 1:

Female Subject presenting for screening mammography
30-80 years of age, inclusive
Able to provide written informed consent

Arm 2:

Female Subject presenting for diagnostic appointment and/or biopsy
30-80 years of age, inclusive
1-3 masses per breast
Masses between 0.5 cm and 3.5 cm only

Exclusion Criteria:

Individuals who are unable to comprehend or unwilling to sign an informed consent form
Women younger than 30 or older than 80
Pregnant women
Women who have undergone bilateral mastectomies
Males
Prisoners
Masses which are larger than 3.5 cm or smaller than 0.5 cm in size
Individuals with more than 3 masses per breast will be excluded due to the complexity of these cases

Study is for people with:

Breast Cancer

Estimated Enrollment:

213

Study ID:

NCT04397029

Recruitment Status:

Terminated

Sponsor:

George Washington University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

George Washington University - Medical Faculty Associates
Washington District of Columbia, 20037, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

213

Study ID:

NCT04397029

Recruitment Status:

Terminated

Sponsor:


George Washington University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.